Joint Society for Integrative Oncology (SIO) Program
The Joint Society for Integrative Oncology (SIO) Program supports SIO investigators and institutions conducting patient-centered clinical trials to strengthen evidence for integrative cancer care.
Funder: Gateway for Cancer Research
Due Dates: November 6, 2026 (tentative current-cycle LOI deadline) | Year-round (LOIs) | By invitation (full grant applications)
Funding Amounts: —
Summary: Supports patient-centered integrative oncology clinical trials conducted by investigators and institutions among SIO’s membership.
Key Information: Full grant application invitations are sent only once annually, around the spring Gateway/SIO peer-review meeting.
Description
Gateway for Cancer Research and the Society for Integrative Oncology (SIO) collaborate to support promising, patient-centered clinical trials in integrative oncology. The program connects Gateway’s support for cancer research with trials conducted by principal investigators and institutions among SIO’s membership.
The collaboration aligns with SIO’s mission to advance evidence-based, comprehensive integrative healthcare that improves the lives of people affected by cancer. By supporting clinical investigation centered on patients, it seeks to strengthen the evidence behind integrative approaches within cancer care.
